Innovations in Tissue Reconstruction and Wound Repair

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: 28 August 2026 | Viewed by 170

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Medicine, Dentistry and Health Sciences, Monash University, Melbourne, Australia
Interests: tissue reconstruction; microsurgery; wound healing; biomaterials; regenerative medicine; AI in surgery; translational innovation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Advances in tissue reconstruction and wound repair are increasingly arising from a deeper understanding of the biological, mechanistic, and translational processes that govern tissue injury, repair, and regeneration. Beyond surgical technique alone, contemporary progress is driven by insights into inflammation, fibroproliferative signalling, angiogenesis, extracellular matrix remodelling, immune modulation, and mechanobiology, with a special emphasis on the application of biomaterials and stem cells. This progress is coupled with diagnostic and biomarker-guided strategies that enable personalised intervention.

This Special Issue, titled “Innovations in Tissue Reconstruction and Wound Repair”, aims to highlight high-quality basic, translational, and clinically integrated research that bridges bench-to-bedside innovation, with a key focus on biomaterials and stem cell-based regenerative approaches. We particularly welcome studies that elucidate wound-healing mechanisms, identify diagnostic or prognostic biomarkers, develop and characterise novel biomaterials (e.g., smart hydrogels, 3D-printed scaffolds), explore stem cell biology, delivery, and efficacy, and translate these biological and material discoveries into improved reconstructive outcomes. Topics of interest include, but are not limited to, fibroproliferative and inflammatory wound disorders; tissue perfusion and microvascular biology; stem cell- and scaffold-based therapies; AI-enabled diagnostics and surgical planning; infection and scar modulation; and the integration of biomaterials with cellular therapies for enhanced regeneration. Clinical studies are encouraged when embedded within mechanistic, diagnostic, or translational frameworks.

By integrating biological insight and advances in biomaterial/stem cell science with reconstructive innovation, this Special Issue seeks to advance the science underpinning tissue repair and guide the next generation of therapeutic strategies in reconstructive surgery and wound healing.

Dr. Ishith Seth
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stem cell therapy
  • tissue engineering
  • tissue reconstruction
  • microsurgery
  • wound healing
  • regenerative medicine
  • biomaterials
  • perforator flaps
  • supermicrosurgery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

8 pages, 1120 KB  
Case Report
Bone Marrow Mononuclear Cells and Plasma Gel as Combination Treatment for Hard-to-Heal Wounds
by Silvia Perez-Lopez, Nuria Vazquez-Garcia, Maria Luz Rodriguez-Martinez, Susana Valerdiz-Casasola, Marcos Perez-Basterrechea, Jose Maria Garcia-Gala, Maria de los Angeles Fernandez-Rodriguez, Eva Martinez-Revuelta and Maria Alvarez-Viejo
Life 2026, 16(5), 847; https://doi.org/10.3390/life16050847 (registering DOI) - 20 May 2026
Abstract
Hard-to-heal wounds pose a significant challenge in clinical practice due to the fact that the conventional treatments used are not always effective. For this reason, it is necessary to design alternatives to achieve an adequate resolution. In this context, a new Advanced Therapy [...] Read more.
Hard-to-heal wounds pose a significant challenge in clinical practice due to the fact that the conventional treatments used are not always effective. For this reason, it is necessary to design alternatives to achieve an adequate resolution. In this context, a new Advanced Therapy product was produced in a Good Manufactured Practices Facility in the setting of a clinical trial authorised for the European Medicines Agency (EUCT 2023-505017-25-02). Briefly, an autologous plasma scaffold containing bone marrow mononuclear cells was applied to a 63-year-old male patient who presented a non-healing wound despite two months of self-care and three months of primary care treatment. After cleaning the affected area, a single-dose plasma scaffold with embedded bone marrow mononuclear cells was applied over the wound. Six weeks after treatment, the wound exhibited remarkable healing with complete closure as evidenced by follow-up assessments at different time points. Quality of life measures significantly improved, aligning with clinical findings, and no adverse effects were observed. While further studies are needed, the issues presented in this case report show the promising results obtained forthe first patient included in the trial and treated with this innovative alternative, which supports the potential of mononuclear cells combined with plasma as a therapeutic option for chronic wounds. Full article
(This article belongs to the Special Issue Innovations in Tissue Reconstruction and Wound Repair)
Show Figures

Figure 1

Back to TopTop